Skip to content

Identification of abnormal DNA methylation modification of the candidate genes of NOTCH signaling pathway and study on their mechanisms in the tetralogy of Fallot

Identification of abnormal DNA methylation modification of the candidate genes of NOTCH signaling pathway and study on their mechanisms in the tetralogy of Fallot

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051811
Enrollment
Unknown
Registered
2021-10-05
Start date
2015-06-30
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tetralogy of Fallot

Interventions

TOF group:Nil

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 3 Years

Inclusion criteria

Inclusion criteria: the TOF group: 1. Signed informed consent; 2. Diagnosed with Tetralogy of Fallot. the control group: 1. Signed informed consent; 2. Children who died accidentally.

Exclusion criteria

Exclusion criteria: the TOF group: chromosome aberration. the control group: 1. Children who died of heart problems; 2. Autopsy found a problem with the heart.

Design outcomes

Primary

MeasureTime frame
The methylation level of the CpG site in the promoter region of the gene;

Countries

China

Contacts

Public ContactShengwei

Children's Hospital of Fudan University

sheng4616@126.com+86 13564370238

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026